Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

by Stephen Ahenkorah, Irwin Cassells, Christophe M. Deroose, Thomas Cardinaels, Andrew R. Burgoyne, Guy Bormans, Maarten Ooms, Frederik Cleeren
Published 2021-04-01

Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission

by Maarten Ooms, Sofie Celen, Ronald De Hoogt, Ilse Lenaerts, Johnny Liebregts, Greet Vanhoof, Xavier Langlois, Andrey Postnov, Michel Koole, Alfons Verbruggen, Koen Van Laere, Guy Bormans
Published 2016-03-01

Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability

by Irwin Cassells, Irwin Cassells, Stephen Ahenkorah, Stephen Ahenkorah, Andrew R. Burgoyne, Michiel Van de Voorde, Christophe M. Deroose, Thomas Cardinaels, Thomas Cardinaels, Guy Bormans, Maarten Ooms, Frederik Cleeren
Published 2021-08-01

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy

by Michiel Van de Voorde, Charlotte Duchemin, Charlotte Duchemin, Reinhard Heinke, Reinhard Heinke, Laura Lambert, Eric Chevallay, Thomas Schneider, Miranda Van Stenis, Thomas Elias Cocolios, Thomas Cardinaels, Thomas Cardinaels, Bernard Ponsard, Maarten Ooms, Thierry Stora, Andrew R. Burgoyne
Published 2021-07-01